Toward gene therapy of primary ovarian failure: Adenovirus expressing human FSH receptor corrects the Finnish C566T mutation

Molecular Human Reproduction

Volumn 14, Issue 1, 2008, Pages 9-15

  Ghadami, M ^a,b,d   Salama, S A ^a   Khatoon, N ^a   Chilvers, R ^a   Nagamani, M ^a   Chedrese, P J ^c   Al Hendy, A ^a,d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d MEHARRY MEDICAL COLLEGE   (United States)

Author keywords

Finnish C566T mutation; Follicle stimulating hormone receptor; Gene therapy of ovarian failure; Infertility; Primary amenorrhea

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYCLIC AMP; CYTOSINE; FOLLITROPIN RECEPTOR; LUCIFERASE; THREONINE;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME ACTIVITY; EXPRESSION VECTOR; FEMALE; FINLAND; FUNCTIONAL ASSESSMENT; GENE INACTIVATION; GENE MUTATION; GENE THERAPY; GENETIC TRANSFECTION; GRANULOSA CELL; HORMONAL REGULATION; NONHUMAN; OVARY INSUFFICIENCY; PRIORITY JOURNAL; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIC AMP; FEMALE; FINLAND; FOLLICLE STIMULATING HORMONE; GENE THERAPY; GENETIC VECTORS; HUMANS; OVARIAN FAILURE, PREMATURE; POINT MUTATION; RECEPTORS, FSH; TRANSFECTION;

ADENOVIRIDAE;

EID: 39449133687     PISSN: 13609947     EISSN: 14602407     Source Type: Journal    
DOI: 10.1093/molehr/gam077     Document Type: Article

References (47)

1. Aittomaki K, Lucerna JL, Pakarinen P, Sistonen P, Tapanainen JS, Gromoll J, Kaskikari R, Sankila EM, Lehvaslaiho H, Engel AR. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell 1995;82:959-968.
2. Al-Hendy A, Wang H, Salama SA. Towards gene therapy of ovarian failure: intraovarian injected adenovirus successfully transduced granulosa and stromal but not germ cells. J Soc Gynecol Investig 2005;12 S659.
3. Allen LA, Achermann JC, Pakarinen P, Kotlar TJ, Huhtaniemi IT, Jameson JL, Cheetham TD, Ball SG. A novel loss of function mutation in exon 10 of the FSH receptor gene causing hypergonadotrophic hypogonadism: clinical and molecular characteristics. Hum Reprod 2003;18 251-256.
4. Beau I, Touraine P, Meduri G, Gougeon A, Desroches A, Matuchansky C, Milgrom E, Kuttenn F, Misrahi M. A novel phenotype related to partial loss of function mutations of the follicle stimulating hormone receptor. J Clin Invest 1998;102:1352-1359.
5. Bett AJ, Prevec L, Graham FL. Packaging capacity and stability of human adenovirus type 5 vectors. J Virol 1993;67:5911-5921.
6. Bick D, Franco B, Sherins RJ, Heye B, Pike L, Crawford J, Maddalena A, Incerti B, Pragliola A, Meitinger T. Brief report: Intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med 1992; 326: 1752-1755.
7. Bousfield GR, Perry WM, Ward DN. Gonadotropins: Chemistry and biosynthesis. In Knobil E, Neill JD (eds). The Physiology of Reproduction. New York: Raven Press, 1994, 1749-1792.
8. Chedrese PJ, Rodway MR, Swan CL, Gillio-Meina C. Establishment of a stable steroidogenic porcine granulosa cell line. J Mol Endocrinol 1998;20: 287-292.
9. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M et al. Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 1998;95 13612-13617.
10. Doherty E, Pakarinen P, Tiitinen A, Kiilavuori A, Huhtaniemi I, Forrest S, Aittomaki K. A novel mutation in the FSH receptor inhibiting signal transduction and causing primary ovarian failure. J Clin Endocrinol Metab 2002;87:1151-1155.
11. Eldadah ZA, Brenn T, Furthmayr H, Dietz HC. Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype. J Clin Invest 1995; 95:874-880.
12. Fan QR, Hendrickson WA. Structure of human follicle-stimulating hormone in complex with its receptor. Nature 2005;433:269-277.
13. Fox KM, Dias JA, Van Roey P. Three-dimensional structure of human follicle-stimulating hormone. Mol Endocrinol 2001;15:378-389.
14. Gillio-Meina C, Swan CL, Crellin NK, Stocco DM, Chedrese PJ. Generation of stable cell lines by spontaneous immortalization of primary cultures of porcine granulosa cells. Mol Reprod Dev 2000;57:366-374.
15. Gromoll J, Weinbauer GF, Simoni M, Nieschlag E. Effects of antiandrogens and ethane dimethane sulphonate (EDS) on gene expression, free subunits, bioactivity and secretion of pituitary gonadotrophins in male rats. Mol Cell Endocrinol 1993;91:119-125.
16. Gromoll J, Dankbar B, Gudermann T. Characterization of the 5′ flanking region of the human follicle-stimulating hormone receptor gene. Mol Cell Endocrinol 1994;102:93-102.
17. Gromoll J, Simoni M, Nordhoff V, Behre HM, De Geyter C, Nieschlag E. Functional and clinical consequences of mutations in the FSH receptor. Mol Cell Endocrinol 1996;125:177-182.
18. Hardelin JP, Levilliers J, del C, I, Cohen-Salmon M, Legouis R, Blanchard S, Compain S, Bouloux P, Kirk J et al. X chromosome-linked Kallmann syndrome: Stop mutations validate the candidate gene. Proc Natl Acad Sci USA 1992;89:8190-8194.
19. Havelock JC, Rainey WE, Carr BR. Ovarian granulosa cell lines. Mol Cell Endocrinol 2004;228:67-78.
20. Kelton CA, Cheng SV, Nugent NP, Schweickhardt RL, Rosenthal JL, Overton SA, Wands GD, Kuzeja JB, Luchette CA, Chappel SC. The cloning of the human follicle stimulating hormone receptor and its expression in COS-7, CHO, and Y-1 cells. Mol Cell Endocrinol 1992;89:141-151.
21. Lapthorn AJ, Harris DC. Littlejohn A, Lustbader JW, Canfield RE, Machin KJ, Morgan FJ, Isaacs NW. Crystal structure of human chorionic gonadotropin. Nature 1994;369:455-461.
22. Layman LC, Lee EJ, Peak DB, Namnoum AB, Vu KV, van Lingen BL, Gray MR, McDonough PG, Reindollar RH, Jameson JL. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone beta-subunit gene. N Engl J Med 1997;337:607-611.
23. Matthews CH, Borgato S, Beck-Peccoz P, Adams M, Tone Y, Gambino G, Casagrande S, Tedeschini G, Benedetti A, Chatterjee VK. Primary amenorrhoea and infertility due to a mutation in the beta-subunit of follicle-stimulating hormone. Nat Genet 1993;5:83-86.
24. Minegishi T, Nakamura K, Takakura Y, Ibuki Y, Igarashi M, Minegish T. Cloning and sequencing of human FSH receptor cDNA. Biochem Biophys Res Commun 1991;175:1125-1130.
25. Pierce JG, Parsons TF. Glycoprotein hormones: Structure and function. Annu Rev Biochem 1981;50:465-495.
26. Rannikko A, Pakarinen P, Manna R, Beau I, Misrahi M, Aittomaki K, Huhtaniemi I. Functional characterization of the human FSH receptor with an inactivating A1a189Val mutation. Mol Hum Reprod 2002;8 311-317.
27. Reindollar RH, McDonough PG. Pubertal aberrancy. Etiology and clinical approach. J Reprod Med 1984;29:391-398.
28. Rhee GS, Lee HJ, Kim SS, Kwack SJ, Lee RD, Seok JH et al. Reproductive safety evaluation and quantification of adenoviral vectors in the mouse. Mol Ther 2004;9:S172.
29. Rousseau-Merck. MF, Atger M, Loosfelt H, Milgrom E, Berger R. The chromosomal localization of the human follicle-stimulating hormone receptor gene (FSHR) on 2p21-p16 is similar to that of the luteinizing hormone receptor gene. Genomics 1993;15:222-224.
30. Salama S, Kamel M, Christman G, Wang H, Al-Hendy A. Gene therapy of uterine fibroids: Adenovirus-mediated Herpes Simplex Virus thymidine kinase/ganciclovir treatment inhibits growth of human and rat leiomyoma cells. Gynecol Obstet Invest 2007 63:61-70.
31. Simoni M, Gromoll J, Nieschlag E. The follicle-stimulating hormone receptor: Biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev 1997;18:739-773.
32. Simoni M, Gromoll J, Hopprier W, Kamischke A, Krafft T, Stahle D, Nieschlag E. Mutational analysis of the follicle-stimulating hormone (FSH) receptor in normal and infertile men: Identification and characterization of two discrete FSH receptor isoforms. J Clin Endocrinol Metab 1999;84:751-755.
33. Simpson CW, Plunkett ER. Pituitary function testing in amenorrhea-galactorrhea-hyperprolactinemia. Fertil Steril 1979; 32:510-517.
34. Simpson JL, Christakos AC, Horwith M, Silverman FS. Gonadal dysgenesis in individuals with apparently normal chromosomal complements: tabulation of cases and compilation of genetic data. Birth Defects 1971;7:215-228.
35. Smida AD, Valderrama. XP, Agostini MC, Furlan MA, Chedrese J. Cadmium stimulates transcription of the cytochrome p450 side chain cleavage gene in genetically modified stable porcine granulosa cells. Biol Reprod 2004;70:25-31.
36. Smits G, Campillo M, Govaerts C, Janssens V, Richter C, Vassart. G, Pardo L, Costagliola S. Glycoprotein hormone receptors: Determinants in leucine-rich repeats responsible for ligand specificity. Embo J 2003;22:2692-2703.
37. Somers JP, DeLoia JA, Zeleznik AJ. Adenovirus-directed expression of a nonphosphorylatable mutant of CREB (cAMP response element-binding protein) adversely affects the survival, but not the differentiation, of rat granulosa cells. Mol Endocrinol 1999;13:1364-1372.
38. Southern PJ, Berg P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet 1982;1:327-341.
39. Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and Infertility, 5th edn. New York: Lippincott Williams & Wilkins, 1994, p. 1152.
40. Sprengel R, Braun T, Nikolice K, Segaloff DL, Seeburg PH. The testicular receptor for follicle stimulating hormone: Structure and functional expression of cloned cDNA. Mol Endocrinol 1990;4:525-530.
41. Tapanainen JS. Aittomaki K, Min J, Vaskivuo T, Huhtaniemi IT. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat Genet 1997;15:205-206.
42. Timmreck LS, Reindollar RH. Contemporary issues in primary amenorrhea. Obstet Gynecol Clin North Am 2003;30:287-302.
43. Touraine P, Beau I, Gougeon A, Meduri G, Desroches A, Pichard C, Detoeuf M, Paniel B, Prieur M, Zorn JR et al. New natural inactivating mutations of the follicle-stimulating hormone receptor: Correlations between receptor function and phenotype. Mol Endocrinol 1999;13 1844-1854.
44. Weiss J, Axelrod L, Whitcomb RW, Harris PE, Crowley WF, Jameson JL. Hypogonadism caused by a single amino acid substitution in the beta subunit of luteinizing hormone. N Engl J Med 1992;326 179-183.
45. Wentz AC. Resistant ovary syndrome. In Adachi A, Hancock JA, Rosenwaks ZE (eds). Reproductive Endocrinology, Surgery, and Technology. Philadelphia: Lippincott-Raver, 1996, 13885-11392.
46. Wu H, Lusthader JW, Liu Y, Canfield RE, Hendrickson WA. Structure of human chorionic gonadotropin at 2.6 A resolution from MAD analysis of the selenomethionyl protein. Structure 1994;2:545-558.
47. Yarney TA, Sairam MR, Khan H, Ravindranath N, Payne S, Seidah NG. Molecular cloning and expression of the ovine testicular follicle stimulating hormone receptor. Mol Cell Endocrinol 1993;93 219-226.